Inherited Metabolic Disorders Diagnosed in Adulthood: A Single Center Experience
OSMANGAZİ JOURNAL OF MEDICINE · 09.06.2026 · 48 (4) · 714-720
DOI: 10.20515/otd.1865030 ↗Kurz gefasst
Fachartikel in der Zeitschrift OSMANGAZİ JOURNAL OF MEDICINE, online erschienen am 09.06.2026. Verfasst von Sabire Gökalp und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Inherited metabolic disorders (IMDs) are traditionally considered pediatric-onset conditions; however, an increasing number of patients are diagnosed in adolescence and adulthood, often presenting with heterogeneous and nonspecific clinical manifestations. This study aimed to describe the clinical spectrum, biochemical findings, genetic diagnoses, and management approaches in transition-age and adult patients diagnosed with IMDs. This retrospective analysis included 18 patients diagnosed with IMDs. Patients aged ≥16 years were included and defined as transition-age individuals to account for the overlap between pediatric and adult presentations. Demographic, clinical, biochemical, and genetic data were collected, and treatment strategies were recorded. Diagnostic evaluation was based on disease specific biochemical assays supplemented by molecular genetic testing. The cohort included 10 females and 8 males, with a mean age at diagnosis of 34.2 years (range: 16–61 years). The diagnostic spectrum was heterogeneous, with alkaptonuria (n = 4) as the most frequent diagnosis, followed by glycogen storage disease type V (n = 2), while the remaining disorders were individually rare. Muscle-related symptoms, including exercise intolerance, myalgia, or rhabdomyolysis, were observed in 8 patients (44.4%), and elevated creatine kinase levels were detected in 9 patients (50.0%). A definitive molecular diagnosis was established in all patients, allowing implementation of disease-specific treatment or targeted management strategies in the majority of cases. Adult-onset IMDs show marked clinical and genetic heterogeneity and frequently present with nonspecific neuromuscular or neurological findings. These results highlight the importance of considering IMDs in adult patients with unexplained multisystem involvement and underscore the role of integrated biochemical and genetic evaluation for accurate diagnosis and timely management.
Zitieren
APA
Gökalp, S., Basan, H., Aktaşoğlu, E. Ö., & Akar, H. T. (2026). Inherited Metabolic Disorders Diagnosed in Adulthood: A Single Center Experience. OSMANGAZİ JOURNAL OF MEDICINE, 48(4), 714-720. https://doi.org/10.20515/otd.1865030
Vancouver
Gökalp S, Basan H, Aktaşoğlu EÖ, Akar HT. Inherited Metabolic Disorders Diagnosed in Adulthood: A Single Center Experience. OSMANGAZİ JOURNAL OF MEDICINE. 2026;48(4):714-720. doi:10.20515/otd.1865030
BibTeX
@article{Gkalp2026,
author = {Gökalp, Sabire and Basan, Hacer and Aktaşoğlu, Ekin Özsaydı and Akar, Halil Tuna},
title = {Inherited Metabolic Disorders Diagnosed in Adulthood: A Single Center Experience},
journal = {OSMANGAZİ JOURNAL OF MEDICINE},
year = {2026},
volume = {48},
number = {4},
pages = {714--720},
doi = {10.20515/otd.1865030}
}
EUVIMED